In the latest trading session,, 1.48 million Tempest Therapeutics Inc (NASDAQ:TPST) shares changed hands as the company’s beta touched -1.95. With the company’s most recent per share price at $9.97 changing hands around $1.72 or 20.91% at last look, the market valuation stands at $36.71M. TPST’s current price is a discount, trading about -322.47% off its 52-week high of $42.12. The share price had its 52-week low at $5.35, which suggests the last value was 46.34% up since then.
Analysts gave the Tempest Therapeutics Inc (TPST) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TPST as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Tempest Therapeutics Inc (NASDAQ:TPST) trade information
Instantly TPST is in green as seen in intraday trades today. With action 48.81%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -8.10%, with the 5-day performance at 48.81% in the green. However, in the 30-day time frame, Tempest Therapeutics Inc (NASDAQ:TPST) is 45.55% up.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 50.16%. The 2025 estimates are for Tempest Therapeutics Inc earnings to increase by 48.05%, but the outlook for the next 5-year period is at 22.92% per year.
TPST Dividends
Tempest Therapeutics Inc is expected to release its next quarterly earnings report in July.
FMR LLC holds the second largest percentage of outstanding shares, with 1.9157% or 0.43 million shares worth $0.95 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 22.75 shares estimated at $0.22 million under it, the former controlled 0.62% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.45% of the shares, roughly 16.71 shares worth around $0.16 million.
